Return to Article Details SURVIVAL STUDY AND SOME FACTORS AFFECTING IN FIRST-LINE GEFITINIB TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER WITH EGFR MUTATION Download Download PDF